Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

KPRX holding history

Kiora Pharmaceuticals Inc in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KPRX overviewAll 13F holders of KPRXFull Q2 2026 holdings

Shares (Q2 2026)
116,011
Value
$305.1K
% of portfolio
<0.1%
Quarters held
9
Since Q2 2022
Holdings of KPRX by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026116,011$305.1K<0.1%+66,478+134.2%AddedHolders
Q1 202649,533$95.6K<0.1%+27,152+121.3%AddedHolders
Q4 202522,381$44.1K<0.1%−22,192−49.8%ReducedHolders
Q3 202544,573$124.8K<0.1%+44,573NewHolders
Q2 20250$00.0%−26,550−100.0%Sold outHolders
Q1 202526,550$79.9K<0.1%+26,550NewHolders
Q4 20240$00.0%−10,114−100.0%Sold outHolders
Q3 202410,114$37.0K<0.1%+10,114NewHolders
Q1 20240$00.0%−92,585−100.0%Sold outHolders
Q4 202392,585$49.1K<0.1%+92,585NewHolders
Q2 20230$00.0%−14,134−100.0%Sold outHolders
Q1 202314,134$47.2K<0.1%+14,134NewHolders
Q3 20220$00.0%−46,440−100.0%Sold outHolders
Q2 202246,440$22.0K<0.1%+46,440NewHolders